599106 Described herein are arylated camphenes of formula (I), processes for their preparation and uses thereof for the manufacture of medicaments for the treatment of diseases, disorders or conditions associated with, or benefiting from stimulation of CB2 receptors. Specific embodiments of the arylate camphenes include the following: methyl-2-(2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl)-7,7-dimethylbicyclo[2.2.1]hept-2-ene-1-carboxylate； 2-(2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl)-1,7,7-trimethylbicyclo[2.2.1]hept-2-ene； and 2-(4-(hydroxymethyl)-7,7-dimethylbicyclo[2.2.1]heptan-2-yl)-5-(2-methyloctan-2-yl)benzene-1,3-diol.
